Literature DB >> 17086762

Melanoma growth and tumorigenicity in models of microgravity.

Masaki Taga1, Keiko Yamauchi, Jesse Odle, Lucrezia Furian, Alamelu Sundaresan, Govindrajan T Ramesh, Neal R Pellis, Richard J Andrassy, Anil D Kulkarni.   

Abstract

INTRODUCTION: Spaceflight involves numerous biological stressors that could affect long-term cancer incidence and tumor behavior. Ground-based models of microgravity can be used to investigate in vitro and in vivo tumor growth as a preparation for later work in space. The incidence of tumor growth and carcinogenesis in microgravity is as yet unknown. Hence, we investigated the effects of modeled microgravity on tumor growth and tumorigenicity using ground-based in vitro and in vivo models.
METHODS: Murine B16-F10 melanoma cells were cultured in a tissue culture flask (FL) and in a rotating-wall vessel bioreactor (BIO) designed by NASA to simulate some aspects of microgravity. We then measured cell growth, melanin production, and apoptosis. After 48 h of cultures in FL and BIO, cells were inoculated subcutaneously in C57BL/6 mice, syngeneic hosts for B16-F10 tumor cells. Tumor sizes were then measured every other day.
RESULTS: BIO cultures had 50% decreases in growth when compared with FL cultures while demonstrating an inversely proportional increase in doubling time. Melanin production (a marker of differentiation) increased at 24 and 48 h in BIO. Flow cytometry analysis demonstrated that there was an increase in the percentage of apoptotic cells in the BIO when compared with that in the FL. When BIO-cultured melanoma cells were inoculated subcutaneously in mice, there was a significant increase in tumorigenicity as compared with FL-cultured cells.
CONCLUSION: Our results indicate that simulated microgravity may have altered the tumor cell characteristics and enhanced the invasive property. It is possible that the microgravity analogue culture environment may have selected highly tumorigenic cells for survival despite the decreased overall growth in the microgravity analogue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086762

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

Review 1.  Using space-based investigations to inform cancer research on Earth.

Authors:  Jeanne L Becker; Glauco R Souza
Journal:  Nat Rev Cancer       Date:  2013-04-12       Impact factor: 60.716

2.  Differential behaviour of normal, transformed and Fanconi's anemia lymphoblastoid cells to modeled microgravity.

Authors:  Paola Cuccarolo; Francesca Barbieri; Monica Sancandi; Silvia Viaggi; Paolo Degan
Journal:  J Biomed Sci       Date:  2010-07-28       Impact factor: 8.410

Review 3.  Microgravity, Stem Cells, and Cancer: A New Hope for Cancer Treatment.

Authors:  Uğur Topal; Cihan Zamur
Journal:  Stem Cells Int       Date:  2021-04-29       Impact factor: 5.443

4.  Simulated microgravity-mediated reversion of murine lymphoma immune evasion.

Authors:  Jillian H Bradley; Shannon Barwick; Gillian Q Horn; Elizabeth Ullrich; Brianna Best; Jennifer P Arnold; Randal K Gregg
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

5.  Effects of simulated microgravity on the expression profiles of RNA during osteogenic differentiation of human bone marrow mesenchymal stem cells.

Authors:  Liang Li; Cui Zhang; Jian-Ling Chen; Fan-Fan Hong; Ping Chen; Jin-Fu Wang
Journal:  Cell Prolif       Date:  2018-11-05       Impact factor: 6.831

6.  Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space.

Authors:  Petra M Wise; Paolo Neviani; Stefan Riwaldt; Thomas J Corydon; Markus Wehland; Markus Braun; Marcus Krüger; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

Review 7.  The Fight against Cancer by Microgravity: The Multicellular Spheroid as a Metastasis Model.

Authors:  Daniela Grimm; Herbert Schulz; Marcus Krüger; José Luis Cortés-Sánchez; Marcel Egli; Armin Kraus; Jayashree Sahana; Thomas J Corydon; Ruth Hemmersbach; Petra M Wise; Manfred Infanger; Markus Wehland
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.